CompletedPhase 2NCT00030680

Radiation Therapy in Treating Patients With Aggressive Fibromatoses

Studying Desmoid tumor

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator: R. B. Keus, MD
Arnhems Radiotherapeutisch Instituut
Intervention: radiation therapy(radiation)
Enrollment: 44 enrolled
Eligibility: 16 years · All sexes
Timeline: 2001 – 2012

Study locations (21)

Cliniques Universitaires Saint-Luc, Brussels, Belgium
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Institut Bergonie, Bordeaux, France
Centre Leon Berard, Lyon, France
CHU de la Timone, Marseille, France
Southwest German Cancer Center at Eberhard-Karls-University, Tübingen, Germany
Arnhems Radiotherapeutisch Instituut, Arnhem, Netherlands
University Medical Center Groningen, Groningen, Netherlands
Leiden University Medical Center, Leiden, Netherlands
Maastro Clinic - Locatie Maastricht, Maastricht, Netherlands
Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands
Dr. Bernard Verbeeten Instituut, Tilburg, Netherlands
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
+6 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00030680 on ClinicalTrials.gov

Other trials for Desmoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoid tumor →

← Back to all trials